Treatment of patients with brain metastases from ovarian cancer: clinical observation
The capacity of drugs to penetrate across the blood-brain barrier (BBB) is primarily traditionally taken into account on choosing chemotherapy (CT) regimens for patients with brain metastatic involvement. P aclitaxel and carboplatin have a low ability to cross the BBB in its normal state. As of now,...
Main Authors: | V. B. Karakhan, D. R. Naskhletashvili, N. V. Sevyan |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-08-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/185 |
Similar Items
-
OVARIAN CANCER WITH SOLITARY BRAIN METASTASIS. A CLINICAL CASE OF PROLONGED (OVER 7 YEARS) COMPLETE REMISSION AFTER COMBINED TREATMENT
by: N. V. Sevyan, et al.
Published: (2018-04-01) -
Supraclavicular metastases from ovarian cancer
by: Nicolae Bacalbasa, et al.
Published: (2023-06-01) -
Combination chemotherapy in the treatment of breast cancer patients with metastatic brain involvement and a poor prognosis
by: D. R. Naskhletashvili, et al.
Published: (2014-07-01) -
CEREBRAL METASTASES CANCER OF THE LARYNX: TWO CASE REPORTS
by: N. V. Sevyan, et al.
Published: (2015-04-01) -
Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers
by: Gloria Mittica, et al.
Published: (2020-05-01)